{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T03:50:18Z","timestamp":1780545018655,"version":"3.54.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2008,9,8]],"date-time":"2008-09-08T00:00:00Z","timestamp":1220832000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2008,9,8]],"date-time":"2008-09-08T00:00:00Z","timestamp":1220832000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1038\/bmt.2008.267","type":"journal-article","created":{"date-parts":[[2008,9,8]],"date-time":"2008-09-08T10:46:31Z","timestamp":1220870791000},"page":"29-36","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":58,"title":["The impact of graft composition on clinical outcomes in unmanipulated HLA-mismatched\/haploidentical hematopoietic SCT"],"prefix":"10.1038","volume":"43","author":[{"given":"X-H","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y-J","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L-P","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D-H","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K-Y","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X-J","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,9,8]]},"reference":[{"key":"BFbmt2008267_CR1","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1038\/sj.leu.2402909","volume":"17","author":"M Mohty","year":"2003","unstructured":"Mohty M, Bilger K, Jourdan E, Kuentz M, Michallet M, Bourhis JH et al. Higher doses of CD34+ peripheral blood stem cells are associated with increased mortality from chronic graft-versus-host disease after allogeneic HLA-identical sibling transplantation. Leukemia 2003; 17: 869\u2013875.","journal-title":"Leukemia"},{"key":"BFbmt2008267_CR2","doi-asserted-by":"publisher","first-page":"3221","DOI":"10.1182\/blood.V98.12.3221","volume":"98","author":"JM Zaucha","year":"2001","unstructured":"Zaucha JM, Gooley T, Bensinger WI, Heimfeld S, Chauncey TR, Zaucha R et al. CD34 cell dose in granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cell grafts affects engraftment kinetics and development of extensive chronic graft-versus-host disease after human leukocyte antigen-identical sibling transplantation. Blood 2001; 98: 3221\u20133227.","journal-title":"Blood"},{"key":"BFbmt2008267_CR3","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.1182\/blood.V88.8.3223.bloodjournal8883223","volume":"88","author":"D Mavroudis","year":"1996","unstructured":"Mavroudis D, Read E, Cottler-Fox M, Couriel D, Molldrem J, Carter C et al. CD34+ cell dose predicts survival, posttransplant morbidity, and rate of hematologic recovery after allogeneic marrow transplants for hematologic malignancies. Blood 1996; 88: 3223\u20133229.","journal-title":"Blood"},{"key":"BFbmt2008267_CR4","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1182\/blood.V68.3.770.770","volume":"68","author":"NA Kernan","year":"1986","unstructured":"Kernan NA, Collins NH, Juliano L, Cartagena T, Dupont B, O'Reilly RJ . Clonable T lymphocytes in T cell-depleted bone marrow transplants correlate with development of graft-v-host disease. Blood 1986; 68: 770\u2013773.","journal-title":"Blood"},{"key":"BFbmt2008267_CR5","doi-asserted-by":"publisher","first-page":"2300","DOI":"10.1182\/blood-2004-04-1473","volume":"105","author":"TM Cao","year":"2005","unstructured":"Cao TM, Shizuru JA, Wong RM, Sheehan K, Laport GG, Stockerl-Goldstein KE et al. Engraftment and survival following reduced-intensity allogeneic peripheral blood hematopoietic cell transplantation is affected by CD8+ T-cell dose. Blood 2005; 105: 2300\u20132306.","journal-title":"Blood"},{"key":"BFbmt2008267_CR6","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1182\/blood.V91.1.347","volume":"91","author":"J Tanaka","year":"1998","unstructured":"Tanaka J, Mielcarek M, Torok-Storb B . Impaired induction of the CD28-responsive complex in granulocyte colony-stimulating factor mobilized CD4 T cells. Blood 1998; 91: 347\u2013352.","journal-title":"Blood"},{"issue":"Suppl 1","key":"BFbmt2008267_CR7","first-page":"205a","volume":"96","author":"JM Zaucha","year":"2000","unstructured":"Zaucha JM, Gooley T, Heimfeld S . The ratio of CD3: CD14 cells and the number of CD34 cells in G-CSF mobilized peripheral blood mononuclear cell (G-PBMC) products are significantly associated with clinical outcome in HLA-identical sibling transplantation. Blood 2000; 96 (Suppl 1): 205a.","journal-title":"Blood"},{"key":"BFbmt2008267_CR8","doi-asserted-by":"publisher","first-page":"3186","DOI":"10.1182\/blood.V98.12.3186","volume":"98","author":"J Morton","year":"2001","unstructured":"Morton J, Hutchins C, Durrant S . Granulocyte-colony-stimulating factor (G-CSF)-primed allogeneic bone marrow: significantly less graft-versus-host disease and comparable engraftment to G-CSF-mobilized peripheral blood stem cells. Blood 2001; 98: 3186\u20133191.","journal-title":"Blood"},{"key":"BFbmt2008267_CR9","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1053\/bbmt.2002.v8.pm12064363","volume":"8","author":"SQ Ji","year":"2002","unstructured":"Ji SQ, Chen HR, Wang HX, Yan HM, Pan SP, Xun CQ . Comparison of outcome of allogeneic bone marrow transplantation with and without granulocyte colony-stimulating factor (lenograstim) donor-marrow priming in patients with chronic myelogenous leukemia. Biol Blood Marrow Transplant 2002; 8: 261\u2013267.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2008267_CR10","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/sj.bmt.1705445","volume":"38","author":"XJ Huang","year":"2006","unstructured":"Huang XJ, Liu DH, Liu KY, Xu LP, Chen H, Han W et al. Haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion for the treatment of hematological malignancies. Bone Marrow Transplant 2006; 38: 291\u2013297.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2008267_CR11","doi-asserted-by":"publisher","first-page":"3065","DOI":"10.1182\/blood-2005-05-2146","volume":"107","author":"DP Lu","year":"2006","unstructured":"Lu DP, Dong L, Wu T, Huang XJ, Zhang MJ, Han W et al. Conditioning including antithymocyte globulin followed by unmanipulated HLA-mismatched\/haploidentical blood and marrow transplantation can achieve comparable outcomes with HLA-identical sibling transplantation. Blood 2006; 107: 3065\u20133073.","journal-title":"Blood"},{"key":"BFbmt2008267_CR12","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1111\/j.1365-2141.2006.06300.x","volume":"135","author":"BR Dey","year":"2006","unstructured":"Dey BR, Spitzer TR . Current status of haploidentical stem cell transplantation. Br J Haematol 2006; 135: 423\u2013437.","journal-title":"Br J Haematol"},{"key":"BFbmt2008267_CR13","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.bcmd.2004.08.016","volume":"33","author":"A Tabilio","year":"2004","unstructured":"Tabilio A, Falzetti F, Zei T, De Ioanni M, Bonifacio E, Battelli F et al. Graft engineering for allogeneic haploidentical stem cell transplantation. Blood Cells Mol Dis 2004; 33: 274\u2013280.","journal-title":"Blood Cells Mol Dis"},{"key":"BFbmt2008267_CR14","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1532\/IJH97.A10227","volume":"79","author":"SH Chen","year":"2004","unstructured":"Chen SH, Li X, Huang XJ . Effect of recombinant human granulocyte colony-stimulating factor on T-lymphocyte function and the mechanism of this effect. Int J Hematol 2004; 79: 178\u2013184.","journal-title":"Int J Hematol"},{"key":"BFbmt2008267_CR15","first-page":"1517","volume":"89","author":"HX Jun","year":"2004","unstructured":"Jun HX, Jun CY, Yu ZX . In vivo induction of T-cell hyporesponsiveness and alteration of immunological cells of bone marrow grafts using granulocyte colony-stimulating factor. Haematologica 2004; 89: 1517\u20131524.","journal-title":"Haematologica"},{"key":"BFbmt2008267_CR16","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.trim.2006.10.002","volume":"17","author":"XJ Huang","year":"2007","unstructured":"Huang XJ, Chang YJ, Zhao XY . Maintaining hyporesponsiveness and polarization potential of T cells after in vitro mixture of G-CSF mobilized peripheral blood grafts and G-CSF primed bone marrow grafts in different proportions. Transpl Immunol 2007; 17: 193\u2013197.","journal-title":"Transpl Immunol"},{"key":"BFbmt2008267_CR17","first-page":"302","volume":"8","author":"Y Liu","year":"2000","unstructured":"Liu Y, Chen S, Yu H . Standardization and Quality Control in Flow Cytometric Enumeration of CD34(+) cells. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2000; 8: 302\u2013306.","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi."},{"key":"BFbmt2008267_CR18","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1097\/00007890-197410000-00001","volume":"18","author":"H Glucksberg","year":"1974","unstructured":"Glucksberg H, Storb R, Fefer A, Buckner CD, Neiman PE, Clift RA et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 1974; 18: 295\u2013304.","journal-title":"Transplantation"},{"key":"BFbmt2008267_CR19","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/0002-9343(80)90380-0","volume":"69","author":"HM Shulman","year":"1980","unstructured":"Shulman HM, Sullivan KM, Weiden PL, McDonald GB, Striker GE, Sale GE et al. Chronic graft-versus-host syndrome in man: a long-term clinicopathologic study of 20 Seattle patients. Am J Med 1980; 69: 204.","journal-title":"Am J Med"},{"key":"BFbmt2008267_CR20","doi-asserted-by":"publisher","DOI":"10.1017\/CBO9780511811692","volume-title":"Multivariable Analysis: A Practical Guide for Clinicians","author":"MH Katz","year":"2006","unstructured":"Katz MH . Multivariable Analysis: A Practical Guide for Clinicians, 2nd edn. Cambridge University Press: Cambridge, 2006."},{"key":"BFbmt2008267_CR21","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1214\/aos\/1176350951","volume":"16","author":"RJ Gray","year":"1988","unstructured":"Gray RJ . A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat 1988; 16: 1141\u20131154.","journal-title":"Ann Stat"},{"key":"BFbmt2008267_CR22","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/sj.bmt.1702542","volume":"26","author":"S Singhal","year":"2000","unstructured":"Singhal S, Powles R, Treleaven J, Kulkarni S, Sirohi B, Horton C et al. A low CD34+ cell dose results in higher mortality and poorer survival after blood or marrow stem cell transplantation from HLA-identical siblings: should 2 \u00d7 10(6) CD34+ cells\/kg be considered the minimum threshold? Bone Marrow Transplant 2000; 26: 489\u2013496.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2008267_CR23","first-page":"363","volume":"389","author":"S Slowman","year":"1994","unstructured":"Slowman S, Danielson C, Graves V, Kotylo P, Broun R, McCarthy L . Administration of GM-\/G-CSF prior to bone marrow harvest increases collection of CD34+ cells. Prog Clin Biol Res 1994; 389: 363\u2013369.","journal-title":"Prog Clin Biol Res"},{"issue":"S1","key":"BFbmt2008267_CR24","first-page":"2509a","volume":"94","author":"C Anasetti","year":"1999","unstructured":"Anasetti C, Heimfeld S, Rowley S, Martin PJ, Petersdorf EW, Woolfrey A et al. Higher CD34 cell dose is associated with improved survival after marrow transplantation from unrelated donors. Blood 1999; 94 (S1): 2509a.","journal-title":"Blood"},{"key":"BFbmt2008267_CR25","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/sj.bmt.1702852","volume":"27","author":"R Morariu-Zamfir","year":"2001","unstructured":"Morariu-Zamfir R, Rocha V, Devergie A, Socie G, Ribaud P, Esperou H et al. Influence of CD34(+) marrow cell dose on outcome of HLA-identical sibling allogeneic bone marrow transplants in patients with chronic myeloid leukaemia. Bone Marrow Transplant 2001; 27: 575\u2013580.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2008267_CR26","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1200\/JCO.1997.15.4.1608","volume":"15","author":"ZS Pavletic","year":"1997","unstructured":"Pavletic ZS, Bishop MR, Tarantolo SR, Martin-Algarra S, Bierman PJ, Vose JM et al. Hematopoietic recovery after allogeneic blood stem-cell transplantation compared with bone marrow transplantation in patients with hematologic malignancies. J Clin Oncol 1997; 15: 1608\u20131616.","journal-title":"J Clin Oncol"},{"key":"BFbmt2008267_CR27","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/sj.bmt.1702606","volume":"26","author":"JD Lickliter","year":"2000","unstructured":"Lickliter JD, McGlave PB, DeFor TE, Miller JS, Ramsay NK, Verfaillie CM et al. Matched-pair analysis of peripheral blood stem cells compared to marrow for allogeneic transplantation. Bone Marrow Transplant 2000; 26: 723\u2013728.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2008267_CR28","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1053\/bbmt.2001.v7.pm11760149","volume":"7","author":"JM Zaucha","year":"2001","unstructured":"Zaucha JM, Zellmer E, Georges G, Little MT, Storb R, Storer B et al. G-CSF-mobilized peripheral blood mononuclear cells added to marrow facilitates engraftment in nonmyeloablated canine recipients: CD3 cells are required. Biol Blood Marrow Transplant 2001; 7: 613\u2013619.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2008267_CR29","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1097\/00007890-198806000-00018","volume":"45","author":"A Bacigalupo","year":"1988","unstructured":"Bacigalupo A, Van Lint MT, Occhini D, Margiocco M, Ferrari G, Pittaluga PA et al. ABO compatibility and acute graft-versus-host disease following allogeneic bone marrow transplantation. Transplantation 1988; 45: 1091\u20131094.","journal-title":"Transplantation"},{"key":"BFbmt2008267_CR30","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/sj.bmt.1703621","volume":"30","author":"G Stussi","year":"2002","unstructured":"Stussi G, Muntwyler J, Passweg JR, Seebach L, Schanz U, Gmur J et al. Consequences of ABO incompatibility in allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2002; 30: 87\u201393.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2008267_CR31","doi-asserted-by":"publisher","first-page":"3429","DOI":"10.1182\/blood-2004-05-1918","volume":"104","author":"SLR Martins","year":"2004","unstructured":"Martins SLR, St. John LS, Champlin RE, Wieder ED, McMannis J, Molldrem JJ et al. Functional assessment and specific depletion of alloreactive human T cells using flow cytometry. Blood 2004; 104: 3429\u20133436.","journal-title":"Blood"},{"key":"BFbmt2008267_CR32","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1038\/sj.leu.2404308","volume":"20","author":"I Yakoub-Agha","year":"2006","unstructured":"Yakoub-Agha I, Saule P, Depil S, Micol JB, Grutzmacher C, Boulanger-Villard F et al. A high proportion of donor CD4+ T cells expressing the lymph node-homing chemokine receptor CCR7 increases incidence and severity of acute graft-versus-host disease in patients undergoing allogeneic stem cell transplantation for hematological malignancy. Leukemia 2006; 20: 1557\u20131565.","journal-title":"Leukemia"},{"key":"BFbmt2008267_CR33","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1182\/blood-2006-02-003996","volume":"108","author":"K Rezvani","year":"2006","unstructured":"Rezvani K, Mielke S, Ahmadzadeh M, Kilical Y, Savani BN, Zeilah J et al. High donor FOXP3-positive regulatory T-cell (Treg) content is associated with a low risk of GVHD following HLA-matched allogeneic SCT. Blood 2006; 108: 1291\u20131297.","journal-title":"Blood"},{"key":"BFbmt2008267_CR34","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1111\/j.1365-2141.2004.04945.x","volume":"125","author":"MA Higman","year":"2004","unstructured":"Higman MA, Vogelsang GB . Chronic graft versus host disease. Br J Haematol 2004; 125: 435\u2013454.","journal-title":"Br J Haematol"},{"key":"BFbmt2008267_CR35","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.blre.2005.01.007","volume":"20","author":"ME Horwitz","year":"2006","unstructured":"Horwitz ME, Sullivan KM . Chronic graft-versus-host disease. Blood Rev 2006; 20: 15\u201327.","journal-title":"Blood Rev"},{"key":"BFbmt2008267_CR36","doi-asserted-by":"publisher","first-page":"2903","DOI":"10.1182\/blood-2005-03-1257","volume":"106","author":"E Zorn","year":"2005","unstructured":"Zorn E, Kim HT, Lee SJ, Floyd BH, Litsa D, Arumugarajah S et al. Reduced frequency of FOXP3+ CD4+CD25+ regulatory T cells in patients with chronic graft-versus-host disease. Blood 2005; 106: 2903\u20132911.","journal-title":"Blood"},{"key":"BFbmt2008267_CR37","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1097\/00007890-200002150-00026","volume":"69","author":"MRM van den Brink","year":"2000","unstructured":"van den Brink MRM, Moore E, Ferrara JLM, Burakoff SJ . Graft-versus-host-disease-associated thymic damage results in the appearance of T cell clones with anti-host reactivity. Transplantation 2000; 69: 446\u2013449.","journal-title":"Transplantation"},{"key":"BFbmt2008267_CR38","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1016\/j.bbmt.2007.09.007","volume":"13","author":"L Dong","year":"2007","unstructured":"Dong L, Wu T, Zhang MJ, Gao ZY, Lu DP . CD3+ cell dose and disease status are important factors determining clinical outcomes in patients undergoing unmanipulated haploidentical blood and marrow transplantation after conditioning including antithymocyte globulin. Biol Blood Marrow Transplant 2007; 13: 1515\u20131524.","journal-title":"Biol Blood Marrow Transplant"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/bmt2008267.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2008267","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2008267.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T11:11:56Z","timestamp":1648033916000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bmt2008267"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9,8]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["BFbmt2008267"],"URL":"https:\/\/doi.org\/10.1038\/bmt.2008.267","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,9,8]]},"assertion":[{"value":"22 February 2008","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2008","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2008","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2008","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}